Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Generation of an EHE Extended Primary Cell Culture

ABSTRACT: Epithelioid hemangioendothelioma (EHE) is a difficult to treat vascular sarcoma defined by mutually exclusive TAZ-CAMTA1 (TC) or YAP-TFE3 (YT) fusion proteins. Human cell line systems are needed to dissect the mechanisms underpinning this cancer and evaluate new therapeutic approaches, however human EHE cell lines have yet to be developed. We have developed a method to generate EHE extended primary cell cultures from human samples and have characterized them. Important aspects are conserved between the tumors and cell cultures including detection of the fusion protein by RT-PCR, expression of CAMTA1 by single cell RNA-Seq, and western blot. The cell cultures display many established characteristics of EHE including proliferation, the ability to grow in an anchorage independent manner and susceptibility to TEAD inhibition. Whole genome sequencing (WGS) showed links to epigenetic modifying complexes known to be recruited by the fusion proteins. RNA-Seq demonstrated upregulation of pathways known to be involved in the progression of the disease including PI3K-Akt signaling, ECM receptor interaction, Hippo signaling pathway, focal adhesion, and proteoglycans in cancer. Continued efforts to generate EHE cultures will aid in the mechanistic understanding of the disease and serve as a platform for testing new therapeutic avenues.

ORGANISM(S): Homo sapiens

PROVIDER: GSE277493 | GEO | 2025/12/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Generation of an EHE Extended Primary Cell Culutre

Project description:Epithelioid hemangioendothelioma (EHE) is a difficult to treat vascular sarcoma defined by mutually exclusive TAZ-CAMTA1 (TC) or YAP-TFE3 (YT) fusion proteins. Human cell line systems are needed to dissect the mechanisms underpinning this cancer and evaluate new therapeutic approaches, however human EHE cell lines have yet to be developed. We have developed a method to generate EHE extended primary cell cultures from human samples and have characterized them. Important aspects are conserved between the tumors and cell cultures including detection of the fusion protein by RT-PCR, expression of CAMTA1 by single cell RNA-Seq, and western blot. The cell cultures display many established characteristics of EHE including proliferation, the ability to grow in an anchorage independent manner and susceptibility to TEAD inhibition. Whole genome sequencing (WGS) showed links to epigenetic modifying complexes known to be recruited by the fusion proteins. RNA-Seq demonstrated upregulation of pathways known to be involved in the progression of the disease including PI3K-Akt signaling, ECM receptor interaction, Hippo signaling pathway, focal adhesion, and proteoglycans in cancer. Continued efforts to generate EHE cultures will aid in the mechanistic understanding of the disease and serve as a platform for testing new therapeutic avenues.

2025-12-01 | GSE277495 | GEO

RNA-Seq of Epithelioid Hemangioendothelioma cell lines

Project description:Epithelioid hemangioendothelioma (EHE) is a rare vascular sarcoma that is associated with a WWTR1-CAMTA1 fusion gene in greater than 90% of cases. Cell lines were generated from WWTR1-CAMTA1 positive murine EHE tumors which also harbor a loss of CDKN2A. RNA sequencing was performed on cell lines.

2022-12-16 | GSE220539 | GEO

scRNA-Seq of Cdkn2a mutant murine Epithelioid Hemangioendothelioma tumors

Project description:Epithelioid hemangioendothelioma (EHE) is a rare vascular sarcoma that is associated with a TAZ-CAMTA1 fusion in greater than 90% of cases and loss of CDKN2A in human EHE tumors is associated with late stage disease. Murine EHE tumors were created by conditionally expressing TAZ-CAMTA1 and conditionally knocking out Cdkn2a within vascular endothelium. Resultant tumors were used for single cell RNA sequencing and compared against age matched wild type mice tissue.

2022-12-16 | GSE220540 | GEO

RNA-Seq of genetically engineered mouse model of Epithelioid Hemangioendothelioma tumors

Project description:Epithelioid hemangioendothelioma (EHE) is a rare vascular sarcoma that is associated with a WWTR1-CAMTA1 fusion gene in greater than 90% of cases. Using an adaptation of the FLEx system, we generated a genetically engineered mouse model of EHE whereby the endogenous Wwtr1 Locus is replaced with an Wwtr1-Camta1 locus. RNA was isolated from the resultant tumors and from control liver tissue and RNA sequencing was performed. Cross species analysis between human and mice tumors demonstrated murine EHE maintains the defining transcriptional features of human EHE.

2021-03-25 | GSE168494 | GEO

RNA-Seq of Human Epithelioid Hemangioendothelioma

Project description:Epithelioid hemangioendothelioma (EHE) is a rare vascular sarcoma that is associated with a WWTR1-CAMTA1 fusion gene in greater than 90% of cases. We aimed to investigate the transcriptional pathways activated in EHE. Total RNA was isolated from EHE tumors from surgical resection or autopsy specimens (n=6) followed by RNA-Seq. The results of this study identified a unique transcriptional profile for EHE and helped to validate a novel murine model of EHE.

2021-03-25 | GSE168493 | GEO

scRNA-Seq of genetically engineered mouse model of Epithelioid Hemangioendothelioma tumors

Project description:Epithelioid hemangioendothelioma (EHE) is a rare vascular sarcoma that is associated with a WWTR1-CAMTA1 fusion gene in greater than 90% of cases. Using an adaptation of the FLEx system, we generated a genetically engineered mouse model of EHE whereby the endogenous Wwtr1 Locus is replaced with an Wwtr1-Camta1 locus. Tumors generated from this mouse model were dissociated and a 10X genomics library preparation was performed. The barcoded library was then deep sequenced.

2021-03-25 | GSE168354 | GEO

YAP1-TFE3 mediates endothelial to mesenchymal transition in epithelioid hemangioendothelioma

Project description:Epithelioid Hemangioendothelioma (EHE) is an ultra-rare vascular sarcoma with a high metastatic rate and a lack of reliable prognostic markers. Because of its rarity, EHE is an understudied disease with limited research tools and few effective treatment options. A thorough understanding of the molecular underpinnings that drive EHE tumorigenesis and facilitate metastasis is essential to discovery of druggable targets that could improve patient outcomes. To better understand this EHE biology we generated transgenic endothelial EHE cell models and observed robust transformation of YAP1-TFE3 (YT) expressing cells resulting in a pro-migratory, anti-apoptotic phenotype. We identified endothelial to mesenchymal transition (EndMT) as a contributing process to this transformation as evidenced by the loss of enothelial gene expression and strong increases in EndMT biomarkers Acta2 and Tgm2. To understand the underlying drivers of this process, we utilized mutant versions of YT and pharmacologic inhibitors to determine that the DNA-binding and dimerization bHLH-LZ domain of YT was necessary for EndMT to occur while canonical TEAD activation was dispensable. This project sheds light on molecular mechanisms of EHE which directly contribute to endothelial transformation.

2025-05-31 | GSE287795 | GEO

The TAZ-CAMTA1 and YAP-TFE3 fusion proteins modulate the basal TAZ/YAP transcriptional program by recruiting the Ada2a-containing histone acetyltransferase complex [rnaseq_3T3]

Project description:The WWTR1(TAZ)-CAMTA1 and YAP1-TFE3 gene fusions are disease defining gene alterations for epithelioid hemangioendothelioma, a vascular cancer. The resultant fusion proteins fuse the C terminus of CAMTA1 and TFE3 in frame to the N terminus of TAZ and YAP, respectively. An unbiased BioID-mass spectrometry/RNAi screen identified YEATS2 and ZZZ3 as components of the Ada2a-containing histone acetyltransferase complex and key interactors of both TAZ-CAMTA1 and YAP-TFE3. An integrative NGS approach including RNA-Seq, ChIP-Seq, and ATAC-Seq showed TAZ-CAMTA1 and YAP-TFE3 transcriptional programs overlap with TAZ and YAP but also drive expression of a novel transcriptome.

2020-12-01 | GSE152736 | GEO